Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.anuhpharma.com | |
Market Cap | 449.35 Cr. | |
Enterprise Value(EV) | 442.70 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 7.22 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 12.42 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.76 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 48.14 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 1.86 | Calculated using Price: 89.67 |
Dividend Yield | 2.23 | Period Ending 2022-03 |
No. of Shares Subscribed | 5.01 Cr. | 50,112,000 Shares |
FaceValue | 5 | |
About Anuh Pharma Ltd. | ||
Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations. |
1 Day |
|
+0.10% |
1 Week |
|
+1.57% |
1 Month |
|
+1.83% |
3 Month |
|
+6.53% |
6 Month |
|
-3.99% |
1 Year |
|
-3.79% |
2 Year |
|
-33.45% |
5 Year |
|
+17.55% |
10 Year |
|
+340.86% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 21.78 | 23.55 | 23.44 | 15.43 | 11.38 | 14.87 | 8.75 | 16.12 | 15.11 | |
Return on Capital Employed (%) | 32.94 | 35.13 | 34.91 | 21.61 | 16.31 | 20.56 | 10.87 | 19.75 | 19.33 | |
Return on Assets (%) | 11.75 | 13.29 | 14.37 | 10.58 | 8.35 | 10.44 | 5.06 | 8.63 | 8.99 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 86 | 101 | 119 | 141 | 150 | 165 | 162 | 191 | 214 | 241 | |
Non Curr. Liab. | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 3 | 2 | |
Curr. Liab. | 77 | 67 | 72 | 47 | 59 | 75 | 163 | 139 | 131 | 161 | |
Minority Int. | |||||||||||
Equity & Liab. | 163 | 168 | 191 | 187 | 208 | 239 | 326 | 333 | 347 | 404 | |
Non Curr. Assets | 22 | 24 | 40 | 50 | 54 | 87 | 103 | 95 | 88 | 97 | |
Curr. Assets | 142 | 144 | 151 | 138 | 154 | 152 | 223 | 238 | 259 | 308 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 163 | 168 | 191 | 187 | 208 | 239 | 326 | 333 | 347 | 404 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 266 | 284 | 326 | 206 | 238 | 321 | 307 | 432 | 487 | 527 | |
Other Income | 4 | 5 | 4 | 8 | 7 | 5 | 4 | 11 | 5 | 6 | |
Total Income | 271 | 289 | 330 | 214 | 245 | 325 | 311 | 443 | 492 | 534 | |
Total Expenditure | -242 | -253 | -289 | -183 | -220 | -291 | -284 | -387 | -439 | -476 | |
PBIDT | 28 | 36 | 41 | 30 | 26 | 35 | 27 | 56 | 53 | 57 | |
Interest | -1 | -1 | -1 | -1 | 0 | -1 | -1 | -2 | -2 | 0 | |
Depreciation | -2 | -3 | -2 | -2 | -2 | -2 | -7 | -15 | -12 | -10 | |
Taxation | -8 | -10 | -12 | -8 | -7 | -9 | -5 | -10 | -9 | -11 | |
Exceptional Items | |||||||||||
PAT | 18 | 22 | 26 | 20 | 17 | 23 | 14 | 28 | 31 | 36 | |
Adjusted EPS | 4 | 4 | 5 | 4 | 3 | 5 | 3 | 6 | 6 | 7 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 2 | 15 | 19 | 17 | 26 | 2 | 7 | 49 | -19 | 29 | |
Cash Fr. Inv. | 4 | -5 | -12 | -5 | -20 | 2 | 3 | -77 | 52 | -8 | |
Cash Fr. Finan. | -6 | -8 | -8 | -9 | -4 | -5 | -7 | 22 | -33 | -19 | |
Net Change | 0 | 2 | -1 | 2 | 2 | -1 | 3 | -5 | 0 | 2 | |
Cash & Cash Eqvt | 0 | 2 | 1 | 3 | 5 | 4 | 7 | 2 | 2 | 4 |
Sat, 03 Jun 2023
Announcement under Regulation 30 (LODR)-Investor Presentation Dear Sir/Madam We are enclosing herewith our Companys Investor Presentation for the month of June 2023.Kindly take the same on record. |
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Submission of Annual Secretarial Compliance Report for Financial Year ended 31/03/2023 |
Sat, 20 May 2023
Announcement under Regulation 30 (LODR)-Dividend Updates Intimation under Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 - Change in Director. |
Tue, 06 Jun 2023 |
|
|
|
Mon, 05 Jun 2023 |
|
|